A client is in the middle of an operation which required general anesthesia. One of the medications used was succinylcholine. The client begins to show signs of body rigidity, increased body temperature and sweating. What is the most important action to take after alerting the healthcare provider?

A. Obtain IV dantrolene sodium from emergency cart: The signs of muscle rigidity, hyperthermia, and diaphoresis during anesthesia indicate malignant hyperthermia, a life-threatening hypermetabolic reaction triggered by succinylcholine or volatile anesthetics. Dantrolene sodium is the definitive treatment; it works by inhibiting calcium release from the sarcoplasmic reticulum in skeletal muscle and preventing further complications. B. Check the client's chart for a history of muscular dystrophy: While muscular dystrophy increases susceptibility to complications from anesthetics, waiting to review the chart delays urgent intervention. The priority is to initiate emergency treatment for malignant hyperthermia rather than retrospective assessment. C. Administer an inhaled anesthetic, such as isoflurane: Inhaled anesthetics like isoflurane are known triggers of malignant hyperthermia. Administering one in this scenario would worsen the hypermetabolic state, increasing the risk of severe complications and death. All triggering agents should be discontinued immediately. D. Apply cold towels to the client's body: External cooling can help manage hyperthermia as an adjunctive measure, but it does not treat the underlying pathophysiology of malignant hyperthermia. Without dantrolene, the hypermetabolic reaction continues, and cooling alone is insufficient to prevent fatal outcomes.